At SILREAL, we guide pharmaceutical, MedTech, and life sciences organizations through the complexities of policy and regulatory environments between Germany and Asia. As a specialized life sciences consulting firm, we align regulatory strategy with your commercial goals, from pricing and reimbursement policy to cross-border healthcare market access. 

​​

​

What sets SILREAL apart from competitors is our ability to foster genuine, high-level dialogue with Chinese government stakeholders, grounded in mutual trust and authentic interest. We maintain direct relationships within the Chinese government and understand the sensitivity required in such engagements. 

​

SILREAL creates a neutral, respectful platform where exchange happens at eye level and with intent. We facilitate bilateral dialogue between German and Chinese policymakers and other stakeholders by providing a trusted, neutral platform to ensure neutrality, credibility, and focus. 

​

Our role is more than advisory: we act as a bridge between two health systems, driven by a shared commitment to improving healthcare cooperation and public health outcomes in both countries. 

Thanks to our track record, we are trusted by ministries and government agencies- including Germany’s Federal Ministry of Health - to resolve specific client challenges through discreet, neutral, and impact-oriented engagement. 

 

 

What We Offer 

We support pharma and life science policy consulting and market entry strategy with expertise that spans EU-China regulatory frameworks, stakeholder mapping, and international government affairs. 

 

• Regulatory & Policy Strategy 
  We develop tailored strategies to engage with regulators and policy stakeholders. This includes market access frameworks, pricing and reimbursement policy, EU HTA, and Asia-specific localization requirements. 

 

• Government Affairs & Public Policy 
  We build and execute public affairs strategies, enable dialogue with ministries, and support stakeholder mapping and positioning. Our services support positioning, influence, and long-term collaboration in both regulatory and political spheres. Build your influence across markets with trusted healthcare policy consulting. 

 

• Policy Monitoring & Intelligence 
  We track regulatory changes and political developments in China and Germany to help clients stay compliant and competitive. From GMP compliance in China to reimbursement pathway changes, we translate complexity into clarity. 

 

• International Policy Exchange 
  We facilitate bilateral exchanges between Asia and Europe, bringing best practices in areas such as digital health, NCD policy, and data regulation to shape long-term alignment across regulatory ecosystems. 

​

Selected Experience – See Full Case Studies Below 
Explore examples of how SILREAL translates policy expertise into real-world impact: 

• Strategic COPD Policy Engagement in China  
  We supported a global pharmaceutical company in driving policy momentum for COPD in China. Our strategic advisory, stakeholder alignment, and go-to-market planning helped integrate COPD into the NBPHS and led to a 12.7% revenue increase.